Tuesday, May 05, 2026 11:39:00 AM
So my thoughts on " sell the news " FWIW.
Biotechs almost always raise funds in the days immediately following a positive announcement ...great trial data , approval etc .
So the natural inclination is to sell the day of the news ...and buy back after the capital raise .
The difference here with UNCY is that we know in advance the Co will be raising $25m in the first 15 days following FDA approval ..by the first tranche of warrants being exercised .
So one can make the case that " sell the news " is being priced in or will be priced in, before the day of approval.
What would tank the stock is if they did a capital raise in addition to having the warrants exercised.
On the day of FDA approval I'l watch to see how UNCY closes .
If it rallies hard on opening but closes lower on heavy volume ( Ala AMRN Dec 2019 ) I'll probably sell half just before the close .
This open up but close lower on heavy volume on a major news day , is in my experience a technical signal not to be ignored ...and trumps any fundamental analysis I may be using to stay long .
Regarding BO
No one is buying UNCY until after FDA approval , terms for stocking and distribution in Fresenius and Da Vita clinics is known and Co's TDAPA application has been accepted
JMO
Kiwi
Biotechs almost always raise funds in the days immediately following a positive announcement ...great trial data , approval etc .
So the natural inclination is to sell the day of the news ...and buy back after the capital raise .
The difference here with UNCY is that we know in advance the Co will be raising $25m in the first 15 days following FDA approval ..by the first tranche of warrants being exercised .
So one can make the case that " sell the news " is being priced in or will be priced in, before the day of approval.
What would tank the stock is if they did a capital raise in addition to having the warrants exercised.
On the day of FDA approval I'l watch to see how UNCY closes .
If it rallies hard on opening but closes lower on heavy volume ( Ala AMRN Dec 2019 ) I'll probably sell half just before the close .
This open up but close lower on heavy volume on a major news day , is in my experience a technical signal not to be ignored ...and trumps any fundamental analysis I may be using to stay long .
Regarding BO
No one is buying UNCY until after FDA approval , terms for stocking and distribution in Fresenius and Da Vita clinics is known and Co's TDAPA application has been accepted
JMO
Kiwi
Recent UNCY News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2026 08:30:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2026 08:30:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/20/2026 08:30:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/12/2026 11:51:50 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/12/2026 10:30:46 AM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/30/2026 11:04:02 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/30/2026 11:02:10 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/30/2026 11:00:08 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/06/2026 01:11:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/30/2026 11:29:20 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/30/2026 10:32:02 AM
- Unicycive shares gain as FDA accepts resubmitted OLC NDA • IH Market News • 01/29/2026 03:01:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2025 10:10:14 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/14/2025 10:09:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 02:12:01 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 11:39:29 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/28/2025 11:30:13 AM
- UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit • PR Newswire (US) • 10/14/2025 06:55:00 AM
